Loss of the ATM gene or kinase inhibition of ATM promotes proteasomal degradation of the CBP protein and breakage of DOT1L-H3K79me signalling, ultimately leading to exhaustion of MLLr-AML cells. The gene discussed is DOT1L; the disease is acute myeloid leukemia.